Sunday 21 January 2018 ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

Optibiotix - big news and validation from India: Buy

By HotStockRockets | Friday 16 December 2016

Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

On 29 November Optibiotix (OPTI) stated: "OptiBiotix reports that it has reached late stage commercial discussions with six commercial partners across its technology and product platforms.". The knockers said "jam tomorrow won't happen". This week the first of the six deals was announced and it is massive. More will follow as Adam Reynolds made clear yesterday exclusively HERE. The news is:

OptiBiotix Health plc announces that it has entered into a joint development agreement (the "Agreement") with a multinational. The Agreement allows for the development of food and Over The Counter ("OTC") products containing OptiBiotix's SlimBiome® technology for the Asian market. The multinational is a major supplier of nutritional solutions to the food, beverage, nutraceutical and pharmaceutical industries within Asia, and increasingly across global markets.

The aim of the Agreement is to develop weight management products containing SlimBiome® technology in a range of foods and OTC products which, if successful, will be launched into the Asian market in the second half of 2017. The Company requires its identity and commercial details to remain confidential and no further details can be disclosed at this time.


The word on the street is that the partner is India super multinational Tata. India has a worse problem than lardbucket UK with diabetes and obesity is a real issue. This deal alone could generate enough cash to make Optibiotix shares look cheap and there are more deals like this that will be announced soon. And that will drive a massive re-rate.

The shares are 64p offer and a buy at up to 80p with a target to sell of 100p+ as the market starts to digest (pun, geddit?) how big this news is.

HotStockRockets will be publishing not one but FIVE hot share tips this month (THE FIRST ON MONDAY at 7.45 AM) which you can access for just £5 and to do that click HERE for your five tips for a fiver!

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on OPTI


Comments are turned off for this article.

Site by Everywhen